Like other activating mutations in the EGFR gene, their frequency is higher among women, Asian patients, patients diagnosed with lung adenocarcinoma and non-smoking patients; they are also mutually exclusive with other molecular alterations [50,51]. The gene discussed is EGFR; the disease is lung adenocarcinoma.